ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
2,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
3,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3,2,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
4,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
5,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
6,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
7,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
8,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
9,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
9,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
9,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
9,4,Death,Death and sudden death,Fatal outcomes,Genrl,Y
10,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
10,2,Headache,Headaches NEC,Headaches,Nerv,N
10,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
10,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
12,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
13,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
13,2,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
14,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
15,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
15,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
16,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
16,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
17,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
18,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
19,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
19,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
20,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
21,1,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
22,1,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
22,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
23,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
24,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
24,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
24,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
25,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
26,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
27,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
28,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
28,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
29,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
30,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
30,2,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,Y
30,3,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
30,4,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
30,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
30,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
31,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
31,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
31,3,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
32,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
32,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
33,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
34,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
35,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
35,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
36,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
36,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
37,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
38,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
38,2,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
39,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
39,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
39,3,Endotracheal intubation,Tracheal therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
39,4,Heart valve replacement,Cardiac valve therapeutic procedures,Cardiac therapeutic procedures,Surg,N
39,5,Hepatic infarction,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
39,6,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
39,7,Liver abscess,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
39,8,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
39,9,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
39,10,Prosthetic valve endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
39,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
39,12,Renal abscess,Urinary tract infections,Infections - pathogen unspecified,Infec,N
39,13,Renal infarct,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
39,14,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
39,15,Splenic abscess,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
39,16,Splenic infarction,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
40,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
40,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
40,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
41,1,Abdominal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
41,2,Biliary tract infection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
41,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
41,4,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
41,5,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,Y
42,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
43,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
43,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
43,3,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
44,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
44,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
45,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
46,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
46,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
47,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
47,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
48,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
49,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
49,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
49,3,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
50,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
51,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
51,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
52,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
52,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
52,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
52,4,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
53,1,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
54,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
55,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
56,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
57,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
58,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
58,2,Lipase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
58,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
59,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
60,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
61,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
61,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
61,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
62,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
63,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
63,2,Enterobacter infection,Enterobacter infections,Bacterial infectious disorders,Infec,N
64,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
65,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
66,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
67,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
68,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
68,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
68,3,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
68,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
68,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
68,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
68,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
69,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
69,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
69,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
69,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
69,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
69,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
70,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
70,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
70,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
70,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
70,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
71,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
71,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
71,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
71,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
71,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
72,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
72,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
72,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
72,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
72,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
72,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
73,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
74,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
75,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
75,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
76,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
77,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
77,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
77,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
78,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
78,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
79,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
79,2,Haematological malignancy,Haematologic neoplasms NEC,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
79,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
80,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
81,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
82,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
82,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
82,3,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
82,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
83,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
83,2,Escherichia bacteraemia,Escherichia infections,Bacterial infectious disorders,Infec,N
84,1,Abdominal adhesions,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,N
84,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
84,3,Gallstone ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
84,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
85,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
86,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
86,2,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
86,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
86,4,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
87,1,Acoustic neuroma,Neuromas,Nervous system neoplasms benign,Neopl,N
87,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
87,3,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
87,4,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
87,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
87,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
87,7,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
87,8,Neurilemmoma benign,Nervous system neoplasms benign NEC,Nervous system neoplasms benign,Neopl,N
87,9,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
88,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
89,1,Acoustic neuroma,Neuromas,Nervous system neoplasms benign,Neopl,N
89,2,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
89,3,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
89,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
89,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
89,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
90,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
90,2,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
90,3,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
90,4,Vestibular disorder,Inner ear disorders NEC,Inner ear and VIIIth cranial nerve disorders,Ear,N
91,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
92,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
92,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
92,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
92,4,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
92,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
93,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
93,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
94,1,Alcoholic pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
95,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
95,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
96,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
96,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
96,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
96,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
96,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
96,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
97,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
98,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
98,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
98,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
98,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
99,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
99,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
99,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
100,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
101,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
102,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
103,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
104,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
104,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
104,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
104,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
104,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
104,6,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
104,7,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
105,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
106,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
107,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
107,2,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
107,3,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
107,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
108,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
108,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
108,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
108,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
109,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
109,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
110,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
110,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
111,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
112,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
112,2,Deafness,Hearing losses,Hearing disorders,Ear,N
112,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
112,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
113,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
113,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
113,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
113,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
114,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
114,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,Y
114,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
114,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
115,1,Deafness,Hearing losses,Hearing disorders,Ear,N
115,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
116,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
116,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
116,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
117,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
117,2,Deafness,Hearing losses,Hearing disorders,Ear,N
117,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
117,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
118,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
119,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
119,2,Deafness,Hearing losses,Hearing disorders,Ear,N
119,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
119,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
119,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
120,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
121,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
121,2,Deafness,Hearing losses,Hearing disorders,Ear,N
121,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
121,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
122,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
122,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
122,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
123,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
123,2,Deafness,Hearing losses,Hearing disorders,Ear,N
123,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
123,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
124,1,Deafness,Hearing losses,Hearing disorders,Ear,N
124,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
125,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
126,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
126,2,Deafness,Hearing losses,Hearing disorders,Ear,N
126,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
126,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
126,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
127,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
127,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,Y
127,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
127,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
128,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
128,2,Deafness,Hearing losses,Hearing disorders,Ear,N
128,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
128,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
129,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
129,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
129,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
130,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
130,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
130,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
130,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
131,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
131,2,Deafness,Hearing losses,Hearing disorders,Ear,N
131,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
131,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
132,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
132,2,Deafness,Hearing losses,Hearing disorders,Ear,N
132,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
132,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
132,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
133,1,Deafness,Hearing losses,Hearing disorders,Ear,N
133,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
134,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
134,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
134,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
135,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,Y
135,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
135,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
135,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
136,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
136,2,Deafness,Hearing losses,Hearing disorders,Ear,N
136,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
136,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
137,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
137,2,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
137,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
138,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
138,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
138,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
138,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
139,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
139,2,Deafness,Hearing losses,Hearing disorders,Ear,N
139,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
139,4,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,Y
139,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
139,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
140,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
141,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
141,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
141,3,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
141,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
142,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
142,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
142,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
142,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
142,5,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
142,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
142,7,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
143,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
144,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
144,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
144,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
144,4,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
144,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
144,6,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
144,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
145,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
145,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
145,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
146,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
146,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
147,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
147,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
147,3,Endotracheal intubation,Tracheal therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
147,4,Heart valve replacement,Cardiac valve therapeutic procedures,Cardiac therapeutic procedures,Surg,N
147,5,Hepatic infarction,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
147,6,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
147,7,Liver abscess,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
147,8,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
147,9,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
147,10,Prosthetic valve endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
147,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
147,12,Renal abscess,Urinary tract infections,Infections - pathogen unspecified,Infec,N
147,13,Renal infarct,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
147,14,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
147,15,Splenic abscess,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
148,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
149,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
149,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
149,3,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
149,4,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
149,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
149,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
149,7,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
149,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
149,9,Skin bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
149,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
150,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
151,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
151,2,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
151,3,Peripheral motor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
151,4,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
151,5,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
151,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
151,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
151,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
151,9,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
152,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
152,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
152,3,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
152,4,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
152,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
152,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
152,7,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
152,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
152,9,Skin bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
152,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
153,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
153,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
154,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
154,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
155,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
155,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
155,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
155,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
156,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
157,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
157,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
157,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
158,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
158,2,Large intestinal obstruction,Large intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
159,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
160,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
161,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
162,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
162,2,Cholestatic liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
162,3,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
162,4,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
162,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
163,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
163,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
163,3,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
164,1,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
164,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
164,3,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
165,1,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
165,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
165,3,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
166,1,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
167,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
168,1,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
168,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
168,3,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
169,1,Cyclic vomiting syndrome,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
170,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
170,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
171,1,Blood fibrinogen decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
171,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
172,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
173,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
174,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
174,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
174,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
174,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
175,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
176,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
